Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells--a potential mechanism for targeting liver anti-fibrotic therapeutics.
@article{Elrick2005GenerationOA, title={Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells--a potential mechanism for targeting liver anti-fibrotic therapeutics.}, author={L. Elrick and Val Leel and M. Blaylock and L. Duncan and M. Drever and G. Strachan and K. Charlton and M. Koruth and Andrew J. Porter and M. Wright}, journal={Journal of hepatology}, year={2005}, volume={42 6}, pages={ 888-96 } }
BACKGROUND/AIMS
Hepatic stellate cells are pivotal to fibrogenesis in the liver and many potential anti-fibrotic therapeutics are required to act on targets within hepatic stellate cells. The aim of this study was to generate a human antibody fragment to hepatic stellate cells.
METHODS
Phage display was used to generate a human monoclonal antibody fragment to a peptide sequence present on an extracellular domain of synaptophysin, a protein expressed on the surface of hepatic stellate cells… CONTINUE READING
Topics from this paper
41 Citations
Using a recombinant single chain antibody for targeting liver myofibroblasts with anti-fibrogenic therapeutics
- Medicine
- 2010
- 1
Discovery of Peptide and Aptamer Ligands for Targeted Drug Delivery to Hepatic Stellate Cells
- Chemistry
- 2016
Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics
- Medicine
- Comparative hepatology
- 2009
- 12
Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy
- Medicine
- Hepatology international
- 2008
- 19
- PDF
Targeted Therapies in Liver Fibrosis: Combining the Best Parts of Platelet-Derived Growth Factor BB and Interferon Gamma
- Medicine
- Front. Med.
- 2015
- 33
- PDF
Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
- Medicine
- The Journal of Pharmacology and Experimental Therapeutics
- 2019
- 11
- Highly Influenced
- PDF
Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury.
- Biology, Medicine
- Journal of hepatology
- 2008
- 78
- PDF
A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A
- Biology, Medicine
- Molecular therapy : the journal of the American Society of Gene Therapy
- 2017
- 40
- PDF
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.
- Biology, Medicine
- Physiological reviews
- 2008
- 2,004
- PDF
References
SHOWING 1-10 OF 28 REFERENCES
Successful Targeting to Rat Hepatic Stellate Cells Using Albumin Modified with Cyclic Peptides That Recognize the Collagen Type VI Receptor*
- Chemistry, Medicine
- The Journal of Biological Chemistry
- 2000
- 137
- PDF
Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA).
- Biology, Medicine
- Liver
- 2001
- 78
Albumin modified with mannose 6‐phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells
- Medicine, Biology
- Hepatology
- 1999
- 149
Targeting hepatic stellate cells for cell-specific treatment of liver fibrosis.
- Medicine
- Frontiers in bioscience : a journal and virtual library
- 2002
- 86
- PDF
Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats.
- Biology, Medicine
- Gastroenterology
- 2001
- 339
Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.
- Medicine, Biology
- The Journal of clinical investigation
- 1998
- 949
- PDF
Hepatic stellate cells as a target for the treatment of liver fibrosis.
- Medicine
- Seminars in liver disease
- 2001
- 448
Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers.
- Biology, Medicine
- Journal of hepatology
- 2002
- 398
Cell-type-specific expression of neural cell adhesion molecule (N-CAM) in Ito cells of rat liver. Up-regulation during in vitro activation and in hepatic tissue repair.
- Biology, Medicine
- The American journal of pathology
- 1996
- 144